FDA处方药广告监管方式研究  

FDA regulation mode for advertising of prescription drugs

作　　者：李延敏[1] 陈蕾[2] 黄志禄[2] 白玉萍[2] 张欣涛[2] 杨悦[1] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳110016 [2]国家食品药品监督管理局药品市场监督办公室,北京100050

出　　处：《中国新药杂志》2012年第13期1453-1456,共4页Chinese Journal of New Drugs

摘　　要：文中运用比较研究法,通过介绍FDA处方药广告监管的发展历程,处方药广告的监管部门、资金来源、处方药广告类型及监管重点,FDA不良广告计划,总结其经验教训,从而为我国药品广告监管方式的完善提供参考,如采取合理利用药品广告监管资源、确保药品广告信息易于理解、提高医药师及公众对药品广告的认识等措施来加强对药品广告的监管。Using method of comparative study, we introduced the development of FDA regulation for pre- scription drug advertising, the division, financial resource, types and main regulation aspects, as well as Bad Ad Program of FDA. Then we summarized the experience and lesson in order to provide references for improving the regulation mode of dug advertising in our country. These include the rational use of regulation resources for drug ad- vertising, ensuring whether the drug advertising information is easy to understand, and improving the awareness of doctors and the public to drug advertising.

关 键 词：处方药广告 监管 不良广告计划 

分 类 号：R95[医药卫生—药学]